# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: BJ-JNT: Joint or bursa

Extent: E+W+S+N.I.

Joint or bursa infections must meet at least one of the following criteria:
Patient has organisms cultured from joint fluid or synovial biopsy
Patient has evidence of joint or bursa infection seen during a surgical operation or histopathologic examination
Patient has at least two of the following signs or symptoms with no other recognized cause: joint pain, swelling, tenderness, heat, evidence of effusion or limitation of motion
AND at least one of the following:
organisms and white blood cells seen on Gram's stain of joint fluid
positive antigen test on blood, urine, or joint fluid
cellular profile and chemistries of joint fluid compatible with infection and not explained by an underlying rheumatologic disorder
radiographic evidence of infection (for example, abnormal findings on X-ray, CT scan, MRI, radiolabel scan (gallium, technetium, etc.))

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/4/division/4.1/division/4.1.1/division/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-4/division-4.1/division-4.1.1/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.